2014 annual financial data
Cartesian Therapeutics 2014 Operating margin
Direct answer
Operating margin was -506.55%.
Operating income was -15,399,000 USD and net income was -12,880,000 USD.
Operating cash flow was -12,686,000 USD.
Get free Cartesian Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 3,040,000 USD
- Operating income
- -15,399,000 USD
- Net income
- -12,880,000 USD
- Operating cash flow
- -12,686,000 USD